✨ Free AI Report
Precipio, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Precipio, Inc.
Company Research

Precipio, Inc.: Business Overview, Financials & Competitive Analysis

Precipio is a healthcare biotechnology company that provides cancer diagnostic products, reagents, and services in the United States, with a focus on diagnostic blood cancer testing services. The company leverages adv...

Analyst-debate audio for Precipio, Inc.

AskCyborg analysts argue the bull and bear cases for Precipio, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
4/ 10Mixed

Cyborg Score thesis

Early-stage cancer diagnostics company with promising technology but unprofitable operations and limited scale, requiring...

Read the full analyst-debate transcript →
Industry Healthcare Biotechnology - Cancer Diagnostics & Laboratory Medicine
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Precipio, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Precipio, Inc. Overview

Pro stress-test →

Precipio is a healthcare biotechnology company that provides cancer diagnostic products, reagents, and services in the United States, with a focus on diagnostic blood cancer testing services. The company leverages advanced molecular and digital imaging technologies to improve accuracy and speed in hematologic disease diagnosis.

Strategic Profile

Pro stress-test →

Precipio develops precision diagnostic solutions integrating digital morphology, immunophenotyping, and molecular testing to improve diagnosis of leukemia and related blood disorders, designed to enhance accuracy and speed of laboratory workflows. The company offers IV-Cell, a proprietary cell culture media, and HemeScreen, a suite of genetic diagnostic panels.

Competitive Landscape

Pro stress-test →

Precipio competes in the blood cancer diagnostics market against established players like T2 Biosystems, Biodesix, and ENDRA Life Sciences. The company differentiates through proprietary culture media (IV-Cell) and rapid genetic diagnostic panels (HemeScreen), targeting laboratory efficiency improvements and diagnostic accuracy in hematologic malignancies.

Industry Context

Precipio, Inc. operates in Healthcare Biotechnology - Cancer Diagnostics & Laboratory Medicine.

Key facts

Founded: 1997 · Headquarters: New Haven, Connecticut, US · Revenue: Growth of 27% YoY · Market cap: $32.7M-$41.6M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Precipio, Inc..

  • Revenue growing 27% year-over-year with improving operational metrics, showing market traction
  • Trading at significant discount to estimated fair value (77.4% below) despite market volatility
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Stock trading above 200-day moving average at $24.08 with renewed institutional interest
  • Q3 2025Multiple hedge funds and institutional investors increased stakes, including AMH Equity raising position 370%
  • +1 moreTrack every material event for Precipio, Inc. as it happens. Explore monitoring →
Get alerted when Precipio, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

T2 Biosystems platformsRapid molecular diagnostic systems for sepsis and other infectious diseases→Biodesix diagnostic testsProtein-based blood tests for cancer and chronic disease management→ENDRA imaging solutionsThermal imaging diagnostic technology for tissue characterization→

Compare Precipio, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Precipio, Inc. operates in Healthcare Biotechnology - Cancer Diagnostics & Laboratory Medicine. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare Biotechnology - Cancer Diagnostics & Laboratory Medicine research →
NEW · MCP server

Ask your AI assistant about Precipio, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Precipio, Inc. and its top competitor on Cyborg Score”
“What did Precipio, Inc. do this quarter?”
“Is Precipio, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Precipio, Inc. do?+
Precipio is a healthcare biotechnology company that provides cancer diagnostic products, reagents, and services in the United States, with a focus on diagnostic blood cancer testing services. The company leverages adv...
What is Precipio, Inc.'s Cyborg Score?+
Precipio, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Precipio, Inc.'s main competitors?+
Named competitors include T2 Biosystems platforms, Biodesix diagnostic tests, ENDRA imaging solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Precipio, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Precipio, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Precipio, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.